If you are a woman aged 45-74 years old, you may be eligible to take part in a breast cancer screening study at The Kirklin Clinic at The University of Alabama at Birmingham. This study, called the Contrast Mammography Imaging Screening Trial (CMIST), is designed to compare two types of mammograms in women with dense breast tissue.

The two types of mammograms in this study are:
• 3D tomosynthesis mammography, which you are already scheduled for.
• Contrast-enhanced spectral mammography (CESM), an additional imaging method.

Both screening options are available at our mammography clinic. Researchers want to determine which method is better at detecting breast cancer early in women with dense breast tissue.

What to Expect if You Participate:
• You will receive both 3D tomosynthesis and CESM mammograms at the start of the study and again one year later.
• Each visit may take up to 3 hours.
• The CESM mammogram is at no charge, while the 3D tomosynthesis mammogram is billed to your insurance.
• We will also collect information from your routine screening mammogram two years after you enter the study.

If you have any questions or are interested in participating, please let us know!

Contact Quenteeria Mooney at 205-934-3747 or qmooney@uabmc.edu.

For additional information about CMIST, please visit: https://www.clinicaltrials.gov/study/NCT05625659
Study Details | Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts | ClinicalTrials.gov